Cargando…
Clinical Implications of Circulating Tumor DNA from Ascites and Serial Plasma in Ovarian Cancer
PURPOSE: The purpose of this study was to identify the clinical utility of circulating tumor DNA (ctDNA) from ascites and serial plasma samples from epithelial ovarian cancer (EOC) patients. MATERIALS AND METHODS: Using targeted next-generation sequencing, we analyzed a total of 55 EOC samples inclu...
Autores principales: | Han, Mi-Ryung, Lee, Sug Hyung, Park, Jung Yoon, Hong, Hyosun, Ho, Jung Yoon, Hur, Soo Young, Choi, Youn Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373868/ https://www.ncbi.nlm.nih.gov/pubmed/32106643 http://dx.doi.org/10.4143/crt.2019.700 |
Ejemplares similares
-
Whole-Exome Sequencing Reveals Clinical Potential of Circulating Tumor DNA from Peritoneal Fluid and Plasma in Endometrial Cancer
por: Ju, Hye-Yeon, et al.
Publicado: (2022) -
Ascites and Serial Plasma Circulating Tumor DNA for Predicting the Effectiveness of Hyperthermic Intraperitoneal Chemotherapy in Patients With Peritoneal Carcinomatosis
por: Pu, Xiaolin, et al.
Publicado: (2022) -
Shallow Whole-Genome Sequencing of Cell-Free DNA (cfDNA) Detects Epithelial Ovarian Cancer and Predicts Patient Prognosis
por: Bak, Seong Eun, et al.
Publicado: (2023) -
Ascitic autotaxin as a potential prognostic, diagnostic, and therapeutic target for epithelial ovarian cancer
por: Choi, Jung-A, et al.
Publicado: (2023) -
Plasma-derived exosomal miR-4732-5p is a promising noninvasive diagnostic biomarker for epithelial ovarian cancer
por: Liu, Jingjing, et al.
Publicado: (2021)